Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Sepsis

Free Subscription 14.10.2019 1 Am J Respir Crit Care Med 1 Am J Trop Med Hyg 5 Chest 2 Clin Infect Dis 1 Crit Care Med 1 J Am Soc Nephrol 1 PLoS One 2 Shock

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Respir Crit Care Med

1. CARLTON EF, McHugh WM, McDonough K, Sturza J, et al
   Markers of Endothelial Dysfunction and Cytokines in High-Risk Pediatric Patients with Severe Sepsis.
   Am J Respir Crit Care Med. 2019 Oct 9. doi: 10.1164/rccm.201904-0910.
   PubMed     Text format    
   
   

   
   Am J Trop Med Hyg

2. KORTZ TB, Nyirenda J, Tembo D, Elfving K, et al
   Distinct Biomarker Profiles Distinguish Malawian Children with Malarial and Non-malarial Sepsis.
   Am J Trop Med Hyg. 2019 Oct 7. doi: 10.4269/ajtmh.18-0635.
   PubMed     Text format     Abstract available
   
   

   
   Chest

3. PATEL JJ, Bergl PA
   COUNTERPOINT: Should Broad-Spectrum Antibiotics Be Routinely Administered to All Patients With Sepsis as Soon as Possible? No.
   Chest. 2019;156:647-649.
   PubMed     Text format    
   
   
4. DISSELKAMP M, Coz Yataco AO, Simpson SQ
   POINT: Should Broad-Spectrum Antibiotics Be Routinely Administered to All Patients With Sepsis as Soon as Possible? Yes.
   Chest. 2019;156:645-647.
   PubMed     Text format    
   
   
5. SERAFIM R, Gomes JA, Salluh J, Povoa P, et al
   Response.
   Chest. 2019;155:244-245.
   PubMed     Text format    
   
   
6. LEVY MM, Rhodes A, Evans LE
   Rebuttal From Drs Levy, Rhodes, and Evans.
   Chest. 2019;155:19-20.
   PubMed     Text format    
   
   
7. MARIK PE, Farkas JD, Spiegel R, Weingart S, et al
   Rebuttal From Drs Marik, Farkas, Spiegel et al.
   Chest. 2019;155:17-18.
   PubMed     Text format    
   
   

   
   Clin Infect Dis

8. EBY JC, Richey MM, Platts-Mills JA, Mathers AJ, et al
   A Healthcare Improvement Intervention Combining Nucleic Acid Microarray Testing with Direct Physician Response for Management of Staphyloccocus aureus Bacteremia.
   Clin Infect Dis. 2017 Aug 17. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
9. PARR JB, Lodge EK, Holzmayer V, Pepin J, et al
   An Efficient, Large-Scale Survey of Hepatitis C Viremia in the Democratic Republic of the Congo Using Dried Blood Spots.
   Clin Infect Dis. 2017 Oct 18. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Crit Care Med

10. NUSSHAG C, Rupp C, Schmitt F, Krautkramer E, et al
    Cell Cycle Biomarkers and Soluble Urokinase-Type Plasminogen Activator Receptor for the Prediction of Sepsis-Induced Acute Kidney Injury Requiring Renal Replacement Therapy: A Prospective, Exploratory Study.
    Crit Care Med. 2019 Oct 4. doi: 10.1097/CCM.0000000000004042.
    PubMed     Text format     Abstract available
    
    

    
    J Am Soc Nephrol

11. GILL JS, Formica RN, Levitsky J
    Transplantation of Kidneys from HCV Viremic Donors in the United States: A Missed Opportunity to Inform Clinical Decision Making and Health Policy.
    J Am Soc Nephrol. 2019;30:1778-1780.
    PubMed     Text format    
    
    

    
    PLoS One

12. TEPARRUKKUL P, Hantrakun V, Imwong M, Teerawattanasook N, et al
    Utility of qSOFA and modified SOFA in severe malaria presenting as sepsis.
    PLoS One. 2019;14:e0223457.
    PubMed     Text format     Abstract available
    
    

    
    Shock

13. SCHEER C, Kuhn SO, Vollmer M, Hahnenkamp K, et al
    Reply to the Letter to the Editor: Earlier Recognition of Sepsis and Septic Shock With Sepsis-3 Criteria - It's Still Early Days!
    Shock. 2019 Oct 7. doi: 10.1097/SHK.0000000000001461.
    PubMed     Text format    
    
    
14. LINDNER HA, Kirschning T, Fairley AM, Oster ME, et al
    Earlier Recognition of Sepsis and Septic Shock With SEPSIS-3 Criteria - It's Still Early Days!
    Shock. 2019 Oct 7. doi: 10.1097/SHK.0000000000001460.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Sepsis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: